Biodistribution and Radiation Dosimetry of the Anti-Her2 Affibody Molecule 68Ga-Aby-025 in Breast Cancer Patients

Journal of Nuclear Medicine- China

doi 10.2967/jnumed.115.169342

Full Text

Abstract

Available in

Categories

Nuclear Medicine

Date

February 9, 2016

Authors

Publisher

Society of Nuclear Medicine

Related search

Comparative Biodistribution and Radiation Dosimetry of 68Ga-Dotatoc and 68Ga-Dotatate in Patients With Neuroendocrine Tumors

Journal of Nuclear Medicine

Nuclear Medicine

English

Benefit of Post Mastectomy Radiation Therapy (PMRT) in Node-Positive, HER2-Positive Patients With Breast Cancer Receiving Anti-Her2 Treatments

International Journal of Radiation Oncology Biology Physics

Cancer Research

Nuclear Medicine

English

Estimation of Radiation Dosimetry for 68Ga-Hbed-Cc (PSMA-11) in Patients With Suspected Recurrence of Prostate Cancer

Nuclear Medicine and Biology

Cancer Research

Nuclear Medicine

Molecular Medicine

English

Biodistribution and Radiation Dosimetry of 99mTc-Hmpao-Labeled Monocytes in Patients With Rheumatoid Arthritis

Journal of Nuclear Medicine

Nuclear Medicine

English

Brain Metastases in Asian HER2-positive Breast Cancer Patients: Anti-Her2 Treatments and Their Impact on Survival

British Journal of Cancer

Cancer Research

English

Developing Anti-Her2 Vaccines: Breast Cancer Experience

International Journal of Cancer

Cancer Research

English

Radiation Dosimetry and Biodistribution of the TSPO Ligand 11c-Dpa-713 in Humans

Journal of Nuclear Medicine

Nuclear Medicine

English

Prospective Study of 68Ga-Nota-Nfb: Radiation Dosimetry in Healthy Volunteers and First Application in Glioma Patients

English

First-In-Human HER2-targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients With Breast Cancer

Journal of Nuclear Medicine

Nuclear Medicine

English